American Gastroenterological Association Institute Technical Review on Prevention and Treatment of Hepatitis B Virus Reactivation During Immunosuppressive Drug Therapy

被引：464
作者：
Perrillo, Robert P. [1 ]
Gish, Robert [2 ,3 ]
Falck-Ytter, Yngve T. [4 ]
机构：
[1] Univ Texas Southwestern, Baylor Univ, Med Ctr, Hepatol Div,Dept Med, Dallas, TX USA
[2] Stanford Univ, Dept Med, Div Gastroenterol & Hepatol, Palo Alto, CA 94304 USA
[3] Hepatitis B Fdn, Doylestown, PA USA
[4] Case Western Reserve Univ, Dept Med, Div Gastroenterol & Hepatol, Case & VA Med Ctr, Cleveland, OH 44106 USA
来源：
GASTROENTEROLOGY | 2015年 / 148卷 / 01期
关键词：
INFLAMMATORY-BOWEL-DISEASE; CHRONIC ACTIVE HEPATITIS; ARTERIAL CHEMOEMBOLIZATION THERAPY; RECEIVING CYTOTOXIC CHEMOTHERAPY; TASK-FORCE RECOMMENDATION; DOSE METHOTREXATE THERAPY; HBSAG-NEGATIVE PATIENTS; BREAST-CANCER PATIENTS; NON-HODGKINS-LYMPHOMA; HBV REACTIVATION;
D O I：
10.1053/j.gastro.2014.10.038
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：221 / U378
页数：27
相关论文
共 104 条
  • [1] Psoriasis, hepatitis B, and the tumor necrosis factor-alpha inhibitory agents: A review and recommendations for management
    Abramson, Amanda
    Menter, Alan
    Perrillo, Robert
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 67 (06) : 1349 - 1361
  • [2] Patients with Inflammatory Bowel Disease Have a Lower Response Rate to HBV Vaccination Compared to Controls
    Altunoz, Mustafa Erhan
    Senates, Ebubekir
    Yesil, Atakan
    Calhan, Turan
    Ovunc, Ayse Oya Kurdas
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2012, 57 (04) : 1039 - 1044
  • [3] [Anonymous], 2014, OPENMETAANALYST VERS
  • [4] [Anonymous], 2012, REV MANAGER REVMAN C
  • [5] American Society of Clinical Oncology Provisional Clinical Opinion: Chronic Hepatitis B Virus Infection Screening in Patients Receiving Cytotoxic Chemotherapy for Treatment of Malignant Diseases
    Artz, Andrew S.
    Somerfield, Mark R.
    Feld, Jordan J.
    Giusti, Andrew F.
    Kramer, Barnett S.
    Sabichi, Anita L.
    Zon, Robin T.
    Wong, Sandra L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (19) : 3199 - 3202
  • [6] Safety of Tumor Necrosis Factor α Blockers in Hepatitis B Virus Occult Carriers (Hepatitis B Surface Antigen Negative/Anti-Hepatitis B Core Antigen Positive) With Rheumatic Diseases
    Caporali, R.
    Bobbio-Pallavicini, F.
    Atzeni, F.
    Sakellariou, G.
    Caprioli, M.
    Montecucco, C.
    Sarzi-Puttini, P.
    [J]. ARTHRITIS CARE & RESEARCH, 2010, 62 (06) : 749 - 754
  • [7] Use of tumor necrosis factor α inhibitors in hepatitis B surface antigen-positive patients: a literature review and potential mechanisms of action
    Carroll, Matthew B.
    Forgione, Michael A.
    [J]. CLINICAL RHEUMATOLOGY, 2010, 29 (09) : 1021 - 1029
  • [8] Entecavir Treatment for up to 5 Years in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B
    Chang, Ting-Tsung
    Lai, Ching-Lung
    Yoon, Seung Kew
    Lee, Samuel S.
    Coelho, Henrique Sergio M.
    Carrilho, Flair Jose
    Poordad, Fred
    Halota, Waldemar
    Horsmans, Yves
    Tsai, Naoky
    Zhang, Hui
    Tenney, Daniel J.
    Tamez, Ricardo
    Iloeje, Uchenna
    [J]. HEPATOLOGY, 2010, 51 (02) : 422 - 430
  • [9] A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B
    Chang, TT
    Gish, RG
    de Man, R
    Gadano, A
    Sollano, J
    Chao, YC
    Lok, AS
    Han, KH
    Goodman, Z
    Zhu, J
    Cross, A
    DeHertogh, D
    Wilber, R
    Colonno, R
    Apelian, D
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (10) : 1001 - 1010
  • [10] Safety of TNF-blocking agents in rheumatic patients with serology suggesting past hepatitis B state: results from a cohort of 21 patients
    Charpin, Caroline
    Guis, Sandrine
    Colson, Philippe
    Borentain, Patrick
    Mattei, Jean-Pierre
    Alcaraz, Patrice
    Balandraud, Nathalie
    Thomachot, Benoit
    Roudier, Jean
    Gerolami, Rene
    [J]. ARTHRITIS RESEARCH & THERAPY, 2009, 11 (06)
12345678910